FDA Issues Accelerated Approval Draft Guidance for Oncology

The FDA is looking for feedback on its newly published draft guidance on designing cancer drug trials intended for the accelerated approval pathway.
Medscape Medical News

source https://www.medscape.com/viewarticle/990242?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?